Sign in

CIK 0002029039 · Non-accelerated filer<br>Emerging growth company

Nasus Pharma Ltd

Sign in to watch
Ticker
NSRX
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
other
EIN
516022712
Phone
972 54-255-3956
Business address
29 HARAKEVET ST, TEL AVIV - YAFO, Israel, 6618003
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-10-08 O'Grady Brendan P. Chief Executive Officer Grant or award · Share options (right to buy) +210,000 210,000
2026-06-17 Teleman Dan Benjamin Chief Executive Officer Purchase +6,550 $3.10 $20K 163,541
2026-04-22 Teleman Dan Benjamin Chief Executive Officer Purchase +2,900 $3.76 $11K 156,991
2026-03-31 Teleman Dan Benjamin Chief Executive Officer Purchase +15,000 $2.04 $31K 21,246

Page 1 of 1 · 4 trades